What is the recommended treatment for DVT in a pregnant woman?

The recommended treatment for deep vein thrombosis (DVT) in a pregnant woman focuses on ensuring the safety of both the mother and the developing fetus. Low molecular weight heparin (LMWH) is favored because it has a well-established safety profile during pregnancy. It provides effective anticoagulation to manage DVT without crossing the placenta, minimizing risks to the fetus.

In addition to LMWH, the use of compression stockings is recommended to help reduce swelling and improve venous return, thus alleviating symptoms associated with DVT and preventing complications like post-thrombotic syndrome.

Other treatments, such as heparin injections, while also anticoagulants, are generally less preferred when LMWH options are available due to the ease of use and dosing of LMWH. Lymph drainage therapy, though beneficial in some cases of lymphatic issues, is not an effective treatment for DVT itself. Oral anticoagulants cannot be used during pregnancy due to their potential to cross the placenta and cause adverse effects.

Thus, the combination of low molecular weight heparin alongside compression stockings represents the most effective and safest management strategy for DVT in pregnant women.